Gynecologic and Andrologic Dermatology and the Metabolic Syndrome

    September 2017 in “ Clinics in Dermatology ”
    María Magdalena Roth, Nicholas Leader, George Kroumpouzos
    Studysummary This study highlights that lower testosterone in men and higher testosterone in women are linked to increased risks of metabolic syndrome and type 2 diabetes, with associated skin diseases indicating potential cardiovascular complications.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on sciencedirect.com →
    Discuss this study in the Community →

    Research cited in this study 34

    1. Cutaneous Manifestations of Polycystic Ovary Syndrome: A Cross-Sectional Clinical Study Indian Dermatology Online Journal · 2017
    2. A Comparison of the Hormonal Profile of Early Androgenetic Alopecia in Men With the Phenotypic Equivalent of Polycystic Ovarian Syndrome in Women JAMA Dermatology · 2016
    3. Association of Metabolic Syndrome With Female Pattern Hair Loss in Women: A Case-Control Study International Journal of Dermatology · 2016
    4. Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome JAMA Dermatology · 2015
    5. Androgenetic Alopecia as an Indicator of Metabolic Syndrome and Cardiovascular Risk Blood Pressure · 2015
    6. Evidence-Based Approach to Cutaneous Hyperandrogenism in Women Journal of The American Academy of Dermatology · 2015
    7. Atherogenic Index of Plasma in Non-Obese Women with Androgenetic Alopecia International Journal of Dermatology · 2015
    8. Is There Really a Relationship Between Androgenetic Alopecia and Metabolic Syndrome? Dermatology Research and Practice · 2015
    9. Is Early Onset Androgenic Alopecia a Marker of Metabolic Syndrome and Carotid Artery Atherosclerosis in Young Indian Male Patients? International Journal of Trichology · 2015
    10. Cardiovascular Risk Factors and Events in Women with Androgen Excess Journal of Endocrinological Investigation · 2014
    11. Polycystic Ovary Syndrome and the Differential Diagnosis of Hyperandrogenism The obstetrician & gynaecologist · 2013
    12. Metabolic Syndrome and Skin: Psoriasis and Beyond Indian Journal of Dermatology · 2013
    13. Animal Models and the Developmental Origins of Polycystic Ovary Syndrome: Increasing Evidence for the Role of Androgens in Programming Reproductive and Metabolic Dysfunction Endocrinology · 2012
    14. Gender-Specific Association of Androgenetic Alopecia with Metabolic Syndrome in a Middle-Aged Korean Population British Journal of Dermatology · 2012
    15. Female Pattern Hair Loss and Metabolic Syndrome in Premenopausal Women Journal of the Egyptian Women's Dermatologic Society (Print) · 2012
    16. Sex Hormone–Binding Globulin and Risk of Hyperglycemia in Patients With Androgenetic Alopecia Journal of The American Academy of Dermatology · 2011
    17. Androgenetic Alopecia and Insulin Resistance: Are They Truly Associated? International Journal of Dermatology · 2011
    18. Polycystic Ovary Syndrome: Dermatological Approach Anais Brasileiros De Dermatologia · 2011
    19. Androgenetic Alopecia and Cardiovascular Risk Factors in Men and Women: A Comparative Study Journal of The American Academy of Dermatology · 2010
    20. Acne Keloidalis Nuchae: A Case Series of Four Indian Patients American Journal of Clinical Dermatology · 2010
    21. Specific Dermatologic Features of Polycystic Ovary Syndrome and Its Association with Biochemical Markers of Metabolic Syndrome and Hyperandrogenism Acta Obstetricia et Gynecologica Scandinavica · 2010
    22. A Comparative Study of Dyslipidemia in Men and Women with Androgenic Alopecia Acta dermato-venereologica · 2010
    23. Hypertension and Aldosterone Levels in Women with Early-Onset Androgenetic Alopecia British Journal of Dermatology · 2009
    24. Androgenic Alopecia and Insulin Resistance: Are They Really Related? Clinical and Experimental Dermatology · 2009
    25. The Androgen Excess and PCOS Society Criteria for the Polycystic Ovary Syndrome: The Complete Task Force Report Fertility and Sterility · 2008
    26. A Prospective Study of the Prevalence of Nonclassical Congenital Adrenal Hyperplasia Among Women Presenting with Hyperandrogenic Symptoms and Signs The Journal of Clinical Endocrinology and Metabolism · 2007
    27. Dermatologic Manifestations of Polycystic Ovary Syndrome American Journal of Clinical Dermatology · 2007
    28. Relative Prevalence of Different Androgen Excess Disorders in 950 Women Referred Because of Clinical Hyperandrogenism The Journal of Clinical Endocrinology and Metabolism · 2006
    29. Health-Related Quality of Life and Physical Well-Being Among a 63-Year-Old Cohort of Women With Androgenetic Alopecia: A Finnish Population-Based Study Health and Quality of Life Outcomes · 2005
    30. The Metabolic Syndrome in Children and Adolescents Paediatrics and Child Health · 2005
    31. Androgenetic Alopecia and Coronary Artery Disease in Women Dermatology Online Journal · 2005
    32. Androgen Excess in Women: Experience with Over 1000 Consecutive Patients The Journal of Clinical Endocrinology and Metabolism · 2004
    33. Hair Loss, Insulin Resistance, and Heredity in Middle-Aged Women: A Population-Based Study European journal of cardiovascular prevention & rehabilitation · 2003
    34. Early Androgenetic Alopecia as a Marker of Insulin Resistance The Lancet · 2000

    Related research 1

    1. Elevated Ghrelin Plasma Levels in Patients with Polycystic Ovary Syndrome Hormone and Metabolic Research · 2004